ScaleReady

We’ve been eager to let you know about the rollout of a $20 million G-Rex Grant Program which goes live today and is accessible to every cell and gene therapy entity that is moving toward, or already conducting, clinical manufacturing. The program goal is to ensure that every recipient is able to establish the most cost effective manufacture of clinical products in the shortest amount of time. To meet that goal, the G-Rex Grant Program includes a wide range of essential products, services, and expertise that will all be made available to recipients. We hope that academic entities and private companies will take advantage of this program. It’s open to all, designed to be very easy to use, and we’re confident that every participant will find it highly beneficial. This program is possible thanks to the participation of forward-thinking collaborators who are dedicated to making a meaningful impact in the field of cell and gene therapy, including Wilson Wolf Manufacturing, LLC, Bio-Techne, CellReady™, Akadeum Life Sciences, Inc., MaxCyte, Inc., and Vector BioMed, Inc. If there are other like-minded entities that have the ability to help propel our goal, please don’t hesitate to reach out to us. We’d also kindly request that people seeing this message repost it so that it reaches the broadest audience possible. You can learn more about how easy it is to become a recipient of a G-Rex Grant here: https://lnkd.in/eWesmsWJ #cellandgenetherapy #GRex #innovation #collaboration

The landscape of CGT manufacturing is constantly evolving. Our poster explores how G-Rex Bioreactors and Heracell Vios Incubators represent a glimpse into the future of safe, efficient, and contamination-controlled production. Download it and see how these innovative systems can propel your CGT operations forward: https://lnkd.in/eNhqhjix #celltherapy #genetherapy #CGT

Want to learn how ScaleReady is helping to build a more sustainable and efficient biotech industry? Listen to this BioProcess International podcast with Josh Ludwig! He discusses the challenges and opportunities facing the industry, and how we're working to overcome them. https://lnkd.in/gnpNKDPa #biotech #sustainability #manufacturing #cellandgenetherapy #patientcare #scaleready

Sustainability in cell and gene therapy goes beyond the environment. We're diving deep into economic and operational dimensions at our ISCT, International Society for Cell & Gene Therapy 2024 session from earlier this year. Watch the recording and learn how to make CGT more affordable and accessible while minimizing your impact: https://bit.ly/4fqQ11K #CGT #Sustainability #ISCT2024 #ScaleReady

We are pleased to announce that BioCytics Inc has been awarded a G-Rex® Grant to accelerate the development of their IND-bound immune fraction, BCyIF1, aimed at combating solid tumors! Read the press release here >>>>  https://lnkd.in/gap7SrPs As stated by Dr. Renaud Warin, BioCytics' Chief Scientific Officer: "This grant will allow us to accelerate the development of our IND-bound immune fraction BCyIF1 against solid tumors. Through this award, we will obtain, at no cost, access to ScaleReady's range of products and low-cost access to the products and expertise of their collaborating companies. The collective cell therapy knowledge base at our disposal is exceptional."   This partnership underscores the potential of ScaleReady's tools and expertise to empower groundbreaking therapies and make a real impact in the fight against cancer.    Are you looking to defray the time and costs of advancing your cell therapy program? Apply for a G-Rex Grant today and join this growing community of innovators!  >>> https://lnkd.in/e8m5j269   Congratulations to the team at BioCytics—we’re excited to see the amazing breakthroughs this grant will help bring to life!   #CellTherapy #GeneTherapy #BiotechInnovation #HealthcareTransformation #GRexGrant   Bio-Techne CellReady™ Wilson Wolf Manufacturing, LLC

Safety and quality are non-negotiable in CGT manufacturing. Our poster explores how G-Rex Bioreactors and Heracell Vios CO2 Incubators can support your efforts to achieve cGMP compliance and deliver high-quality cell and gene therapies. Download it to gain valuable insights: https://lnkd.in/eNhqhjix #celltherapy #genetherapy #CGT

The biotech industry is facing a talent shortage. But did you know that decentralized manufacturing can help address this issue? In this BioProcess International podcast episode, Josh Ludwig and Germfree explore how a more distributed model can develop a stronger talent pipeline. https://lnkd.in/gnpNKDPa #biotech #sustainability #manufacturing #cellandgenetherapy #patientcare #scaleready #talent #biotechjobs

The potential of cell and gene therapy is limitless. But to realize its full potential, we need to address key challenges. This Drug Discovery World article explores these challenges and Josh Ludwig highlights how ScaleReady is working to overcome them. Don't miss it! Read the full article: https://lnkd.in/eX-_e_rc #CGT #CellTherapy #Innovation

Happy World Kindness Day! 🌍 Let's embrace kindness as the norm by performing a random act of kindness today. Share your act of kindness in the comments to inspire others and contribute to normalizing kindness around the world. 🌟 7 ways to start making kindness the norm in your life: https://lnkd.in/gUZb3ng #WorldKindnessDay

Are you in the cell and gene therapy industry? You won't want to miss this! Ignacio Nunez, COO of CellReady™, talks about the company's latest projects and the future of the industry in a recent interview. Watch now and share your thoughts! https://lnkd.in/eCj_gmb3 #cellandgenotherapy #biotech #innovation #watchnow